NYXOAH SA

NYXOAH SA

Nyxoah SA develops neurostimulation devices. The Company offers tiny implantable neurostimulator for the treatment of sleep disorder breathing conditions. Nyxoah serves healthcare sectors in Belgium.

Stock Performance Snapshot

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring NYXH

Rest & Recharge

Rest & Recharge

Tap into the booming wellness economy with companies revolutionizing how we sleep and relax. These carefully selected stocks represent innovative leaders in sleep technology, relaxation services, and wellness solutions that are responding to our growing desire for better rest and recovery.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Confirm the issuer

Start by identifying the company behind NYXH and reviewing official filings; understanding the business reduces basic uncertainty.

⚑

Watch liquidity

Low trading volume can cause big price swings and execution risk, so check average daily volume and spreads before trading.

🌍

Assess fundamentals

Look at revenue, cash flow and debt and compare to peers; remember fundamentals matter, but performance can still vary.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions